Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma

Introduction: Non-Hodgkin Lymphoma patients respond differently to therapy according to inherent biological variations. Pretherapy biomarkers may improve dose-response prediction. Materials and Methods: Hybrid single-photon emission computed tomography (SPECT)/computed tomography (CT) three-dimensio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Biother Radiopharm
Autors principals: Roberson, Peter L., Smith, Lauren B., Morgan, Meredith A., Schipper, Matthew J., Wilderman, Scott J., Avram, Anca M., Kaminski, Mark S., Dewaraja, Yuni K.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5695749/
https://ncbi.nlm.nih.gov/pubmed/29083933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2017.2182
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars